Open Innovation Partner
You may also like
TecTraum Announces Completion of Clinical Trial
TecTraum Announces Completion of Clinical Trial
11 May, 2022TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool® Device for the Treatment of Concussions
TecTraum’s pro2cool Receives FDA Designation as Breakthrough Device
TecTraum’s pro2cool Receives FDA Designation as Breakthrough Device
16 November, 2021TecTraum’s pro2cool Receives FDA Designation as Breakthrough Device
Study Finds pro2cool Reduces Adolescent Concussion Symptoms
Study Finds pro2cool Reduces Adolescent Concussion Symptoms
25 April, 2024Research led by Akron Children’s Hospital finds that pro2cool's hypothermic therapy reduces symptom severity after concu...
Submit a comment